Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,308 | 243 | 99.9% |
| Education | $8.45 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,044 | 128 | $0 (2024) |
| Gilead Sciences, Inc. | $1,501 | 36 | $0 (2024) |
| ABBVIE INC. | $1,133 | 26 | $0 (2024) |
| Intra-Sana Laboratories | $460.08 | 21 | $0 (2024) |
| Boston Scientific Corporation | $274.23 | 2 | $0 (2022) |
| Ardelyx, Inc. | $247.50 | 2 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $214.95 | 15 | $0 (2024) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $105.05 | 4 | $0 (2023) |
| ORPHALAN INC | $97.59 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,206 | 31 | ABBVIE INC. ($305.42) |
| 2023 | $2,159 | 86 | Gilead Sciences, Inc. ($678.14) |
| 2022 | $1,762 | 73 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($745.40) |
| 2021 | $1,189 | 54 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($495.77) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $123.57 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.81 | General |
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $48.01 | General |
| Category: Gastroenterology | ||||||
| 12/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $35.86 | General |
| 11/17/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $57.78 | General |
| Category: INFLAM | ||||||
| 11/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.81 | General |
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: HCV | ||||||
| 08/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $132.02 | General |
| Category: VIROLOGY | ||||||
| 07/24/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $111.84 | General |
| Category: GALLSTONES | ||||||
| 07/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.57 | General |
| 04/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Gastroenterology | ||||||
| 04/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Gastroenterology | ||||||
| 04/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Gastroenterology | ||||||
| 03/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Gastroenterology | ||||||
| 03/12/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: GALLSTONES | ||||||
| 03/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: VIROLOGY | ||||||
| 03/05/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Alagille syndrome | ||||||
| 03/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Gastroenterology | ||||||
| 03/04/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GALLSTONES | ||||||
| 03/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.12 | General |
| 02/28/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Hepatology | ||||||
| 02/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: VIROLOGY | ||||||
| 02/15/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.74 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 194 | 297 | $102,135 | $23,810 |
| 2022 | 3 | 174 | 241 | $81,710 | $19,038 |
| 2021 | 3 | 203 | 259 | $81,755 | $20,792 |
| 2020 | 3 | 105 | 171 | $58,980 | $13,174 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 254 | $81,280 | $19,260 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $20,855 | $4,550 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 187 | $59,840 | $14,380 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $18,430 | $4,083 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $3,440 | $575.13 | 16.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 130 | $41,600 | $10,777 | 25.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 46 | 46 | $22,310 | $5,292 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 83 | $17,845 | $4,723 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 139 | $44,480 | $9,999 | 22.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 17 | $7,225 | $1,594 | 22.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $7,275 | $1,580 | 21.7% |
About Cassandre Oscar, ARNP
Cassandre Oscar, ARNP is a Family healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1366794877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cassandre Oscar, ARNP has received a total of $6,316 in payments from pharmaceutical and medical device companies, with $1,206 received in 2024. These payments were reported across 244 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($6,308).
As a Medicare-enrolled provider, Oscar has provided services to 676 Medicare beneficiaries, totaling 968 services with total Medicare billing of $76,813. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Las Vegas, NV
- Active Since 10/08/2012
- Last Updated 04/25/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1366794877
Products in Payments
- XIFAXAN (Drug) $2,034
- Epclusa (Drug) $863.23
- MAVYRET (Drug) $751.94
- RELTONE 200 MG (Drug) $447.52
- CREON (Drug) $279.61
- IBSRELA (Drug) $247.50
- OCALIVA (Drug) $214.95
- General - Embolics (Device) $149.41
- DUPIXENT (Biological) $125.00
- GENERAL EMBOLICS (Device) $124.82
- CUVRIOR (Drug) $97.59
- TERLIVAZ (Drug) $80.92
- Livdelzi (Drug) $57.78
- LINZESS (Drug) $29.81
- LOKELMA (Drug) $22.60
- Avastin (Biological) $20.94
- Tecentriq (Biological) $19.91
- LIVTENCITY (Drug) $19.43
- Livmarli (Drug) $18.97
- GLYCATE (Drug) $12.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Las Vegas
Mr. John Phoenix, Aprn, APRN
Family — Payments: $106,824
Mrs. Hollie Tyler, Fnp-C, FNP-C
Family — Payments: $101,139
Alex Lapasaran, Aprn-C, APRN-C
Family — Payments: $33,566
Erin Wilkinson, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $29,776
Anna Melisa Lopez-Sanglay, Aprn, Fnpbc, Bsn, Rn, APRN, FNPBC, BSN, RN
Family — Payments: $27,669
Kelly Papesh, Cnp, CNP
Family — Payments: $23,072